The FDA’s approval of the Wegovy oral semaglutide pill in late December 2025 offers a needle-free weight management option, though it requires more rigorous dosing than the injectable version. According to Dr. Anthony Puopolo, Chief Medical Officer at LifeMD, the pill delivers the same molecule as the shot but faces biological barriers that demand strict … Read more
GLP-1 medications like Ozempic and Wegovy produce highly variable results, with some patients losing over 20 percent of their body weight while others see minimal change or even gain weight. According to research from the 23andMe Research Institute and insights from Dr. Anthony Puopolo, this disparity is driven by a complex mix of genetics, eating … Read more
Beyond the Needle: The Future of Weight Management and the Oral Semaglutide Shift The landscape of metabolic health is shifting beneath our feet. With the FDA’s approval of oral semaglutide, the conversation has moved from “Can I lose weight?” to “How do I maintain this safely for the long haul?” As an industry observer who … Read more